China NMPA Product Recall - BIRMINGHAM HIP Manual Instrument for Hip Surgery

Smith & Nephew Surgical Implants Ltd. has voluntarily initiated a Class II recall for its BIRMINGHAM HIP Manual Instrument, a device intended for hip surgery. This recall, published on July 27, 2021, is overseen by the National Medical Products Administration (NMPA), the primary regulatory body responsible for medical devices in China. The provided document does not specify inspection dates; instead, it focuses on the recall event itself.

While the public announcement does not elaborate on the specific issues or violations that prompted this action, a Class II recall typically addresses situations where a product defect could lead to temporary or reversible adverse health consequences, or where the likelihood of serious harm is remote. The company has made detailed information regarding affected models, specifications, and batch numbers available in a 'Medical Device Recall Event Report Form.' This form serves as the official record for the incident and outlines the required actions for healthcare providers and distributors to identify, quarantine, and return or manage the recalled instruments. Smith & Nephew is expected to ensure full compliance with NMPA's regulatory requirements throughout this recall process, prioritizing patient safety and product integrity.